45: The first injection: Rates of urinary retention in women with urgency incontinence treated with intravesical onabotulinumtoxinA (Botox) injection

To describe rate and risks for symptomatic and asymptomatic urinary retention requiring catheterization in women undergoing initial intravesical onabotulinumtoxinA (Botox) injection for urgency urinary incontinence (UUI).

Source: American Journal of Obstetrics and Gynecology - February 28, 2020 Category: OBGYN Authors: N.A. Squires, M.G. Mueller, C. Lewicky-Gaupp, S.A. Collins, K. Kenton, J. Geynisman-Tan Tags: Non-Oral Poster Source Type: research